NCT02880345 2019-04-23RADVAXâ„¢: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 MonotherapyAbramson Cancer Center at Penn MedicinePhase 1 Withdrawn